Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/156287
Full metadata record
DC FieldValueLanguage
dc.creatorBotelho, F
dc.creatorLopes, R
dc.creatorPina, F
dc.creatorSilva, C
dc.creatorPacheco-Figueiredo, L
dc.creatorLunet, N
dc.date.accessioned2024-01-05T15:10:04Z-
dc.date.available2024-01-05T15:10:04Z-
dc.date.issued2023
dc.identifier.issn2045-2322
dc.identifier.urihttps://hdl.handle.net/10216/156287-
dc.description.abstractDifferent treatment options exist for localized prostate cancer. Treatments performed in high-volume hospitals are associated with better results. Our objective was to describe time trends in prostate cancer treatments in Portugal and case volume per hospital. We used the national database of diagnosis-related group of the Portuguese Central Administration of the Health System to describe the number of radical prostatectomy (RP), brachytherapy (BT) and external radiotherapy (eRT) treatments performed in all National Health System hospitals. There was a rapid increase in the annual number of RP until 2006 and then a deceleration; BT treatments augmented significantly until 2011. The utilization of eRT also increased, surpassing RP after 2010. From the 46 hospitals performing RP, only eight had a case-volume > 50 treatments/year, and from the nine hospitals performing BT, only four accomplished > 15 treatments/year. In the 11 hospitals with eRT, nine performed > 50/year. Regarding RP, there was negative correlation between the hospital volume and length of stay (r = − 0.303; p = 0.041). In the Portuguese National Health Service there was a steep increase in the number of prostate cancer treatments, and there is an ample margin for concentration of RP and BT treatments, for improvement of the hospitals case volume. © 2023, The Author(s).
dc.description.sponsorshipWe are grateful to the Administração Central do Sistema de Saúde (ACSS) as the source of the data and Drª. Lucybell Moreira of Centro Hospitalar de S. João for extracting the data used in the manuscript. This work has been funded by National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020.
dc.language.isoeng
dc.publisherNature Research
dc.relationUIDB/50026/2020
dc.relationUIDP/50026/2020
dc.relation.ispartofSci Rep. 2023 Nov 8;13(1):19362. doi: 10.1038/s41598-023-46591-1
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleProstate cancer treatment in Portugal: a nationwide analysis
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto
dc.identifier.doi10.1038/s41598-023-46591-1
dc.relation.publisherversionhttps://www.nature.com/articles/s41598-023-46591-1
Appears in Collections:ISPUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
botelho-sr23-arcio.pdf1.08 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons